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Abstract
The persistence of an epidemic of obesity and type 2 diabetes suggests that new nutritional
strategies are needed if the epidemic is to be overcome. A promising nutritional approach
suggested by this thematic review is metabolic effect of low glycaemic-index diet.
The currently available scientific literature shows that low glycaemic-index diets acutely induce a
number of favorable effects, such as a rapid weight loss, decrease of fasting glucose and insulin
levels, reduction of circulating triglyceride levels and improvement of blood pressure.
The long-term effect of the combination of these changes is at present not known.
Based on associations between these metabolic parameters and risk of cardiovascular disease,
further controlled studies on low-GI diet and metabolic disease are needed.
Reviews
Obesity is a major global health problem that has been
associated with highly occurring disorders such as hyper-
tension, type 2 diabetes, hyperinsulinemia, dyslipidemia,
atherosclerosis and certain types of cancer [1,2]. More
than one billion adults worldwide are overweight, with ≥
300 million clinically obese [3]. The epidemic of over-
weight and obesity, which is rising worldwide, inflicts not
only a reduced quality of life and large healthcare-associ-
ated costs, but also an increased risk of death [4].
Trend analysis in relation to obesity suggests that in most
countries the majority of the population is less active than
they should be for maintaining good health, while they
are simultaneously eating more than they need [5].
Weight gain is considered as a consequence of excessive
energy intake as compared with energy expenditure, while
successful weigh loss depends upon achieving negative
energy balance [2]. In this context, environmental influ-
ences, such as an inactive lifestyle and the consumption of
energy-dense diets, appear of overriding importance on
excessive weight gain in addition to genetic predisposition
[6].
Weight management in the obese may take into account
the energy intake and the dietary macronutrient distribu-
tion.
A number of nutritional approaches and diets with differ-
ent proportions of lipids, proteins and carbohydrates are
being investigated, which may be energy restricted or pre-
scribed [7,8]. Not only the different macronutrient com-
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and specific dietary components could also be important
[9].
The prescription of nutritionally equilibrated low-energy
diets is a common strategy for body-weight reduction
[10].
Table 1. Influence of the different diets on weight loss
[11,12]
Low energetic diets can achieve short-term weight loss,
but often the slimming process is not sustainable in the
long term [13].
The traditional nutritionally adequate low energy diets
frequently failed to promote stable weight losses, and the
explanations for such limited success were mostly the
"poor adherence" to specific low-energy diets.
A study about the effect of energy restriction and diet com-
position on weight loss and changes in plasma lipids and
glucose levels concluded that all energy-restricted diets
improve glucose control independently of diet composi-
tion, while only the lipoprotein profile was affected by the
macronutrient composition [14].
Recently, diets low in carbohydrate (low- carbohydrate
diets) have become the focus of international attention
since the recent WHO recommendations to reduce the
overall consumptions of sugars and some health profes-
sionals recommendations to reduce the consumption of
rapidly digestible starches that lead to high glucose
responses [15].
A study about the influence of low-carbohydrate or low-
fat diet on weight loss and risk factors for atherosclerosis
in the elderly, obese patients with type 2 diabetes mellitus,
shows that the results were more obvious in patients with
carbohydrate-restricted diet, with a relative improvement
in insulin sensitivity and triglycerides levels [12].
High protein low-carbohydrate diets have been proposed
as an alternative to conventional diets, in order to reduce
or treat the risk of obesity, CVD and type 2 diabetes mel-
litus [16].
But this carbohydrate restriction produces a depletion of
glycogen stores leading to excretion of bound water, and
ketogenic effect.
It has been proposed that the glycaemic index of foods can
influence body-weight control [17]. Short-term studies
suggest that low-glycaemic index carbohydrates and fiber
intake could delay hunger and decrease subsequent
energy intake compared with high-glycaemic index foods
[18].
The glycaemic index (GI) is defined as "the incremental
area under the blood glucose curve following ingestion of
a test food, expressed as a percentage of the corresponding
area following an equivalent load of a reference carbohy-
drate, either glucose or white-wheat bread"[19,20].
The GI of a food will vary depending on the rate of diges-
tion. The faster the digestion of a food, the higher is the GI
value (>70).
Also, the GI is defined as Food with a low GI (≤ 70) are
considered to be favorable in terms of health, particularly
for the prevention of obesity, T2DM, and CVD. The GI is
affected by a number of factors:
1 the type of carbohydrate (glucose, 138; maltose, 105;
saccharose, 75; fructose, 30);
2 the fat and protein content of food (a lower GI is associ-
ated with a slowing of gastric emptying);
3 acidity affects gastric emptying and hence the GI a food,
the addition of citric acid or other fruits will therefore
lower the GI;
4 the physical properties of food (i.e., water content);
5 the presence of viscous soluble fibers; ripeness, cooking,
or processing that renders the carbohydrate more digesti-
ble (e.g., starch) will increase the GI;
6 the presence of other factors (i.e., insoluble fiber as
found in whole intact grains) that slow absorption of the
carbohydrate.
Table 1: Influence of different diets on weight loss.
TYPE OF DIET WEEKS WEIGHT LOSS WAIST LOSS
Low energy diets (800–1200 kcal/zi) 14 weeks 7–13 kg 10 cm waist
Very-low energy diet (400–800 kcal/zi) 2 weeks 4–5 kg -
High protein diet (30%) 12 weeks 7–9, 5 kg 8–9 cm waist
Low fat diet (20%) 24 weeks 5–6, 5 kg 6–7 cm waistPage 2 of 8
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rise in the level of blood glucose, a large insulin response,
and glucagons release is strongly inhibited. Low-GI foods
may also delay the return of hunger, by slowing gastric
emptying. Many low-GI foods are high in fiber content,
which prolongs the distension of the gastrointestinal tract,
causing increased and prolonged secretion of the gut pep-
tides cholecystokinin, ghrelin, glucagons, glucagons-like-
peptid-1, and glucose-dependent insulinotropic polypep-
tide, all of which have been suggested as potential satiety
factors [21,22].
A. Metabolic effects of low glycaemic-index diets
Observational studies indicate that the GI of the diet may
be an important determinant of metabolic risk. The major
sources of carbohydrate in the Western diet (highly-
refined cereal and potato products) tend to have high GI
values, which has been linked to the widespread occur-
rence of type 2 diabetes and CVD [23].
GI has been shown to be positively associated with the
prevalence of the metabolic syndrome and insulin resist-
ance in a cross -sectional study of 2834 subjects from the
Framingham Offspring cohort [24]. Odds of having met-
abolic syndrome were reported to be 41% higher in the
highest quintile of dietary GI compared with the lowest
quintile (median GI values 84 and 72 respectively), and
insulin resistance was found to be increased across quin-
tiles (p < 0.001) [23].
Associations have also been reported between GI and
both unfavorable lipid profiles and raised inflammatory
status. In 280 women aged 45–70 years from the Nurses
Health Study fasting triacylglycerol levels were shown to
be positively related to GI [25]. Serum HDL levels have
been found to be negatively related to GI in 1420 subjects
aged 18–64 years from the 1986–7 Survey of Britain
Adults 18–64 years [26], in which GI was the only dietary
factor found to be significantly associated with HDL levels
in multiple linear-regression analysis. Plasma levels of
high-sensitivity C-reactive protein, a sensitive marker of
systemic inflammation, were found to be positively asso-
ciated with both GI and GL in 244 women from the
Nurses' Health Study, aged 45–82 years, with a stronger
relationship in overweight women than in normal-weight
women [27].
Fig. 1. Low GI diets and metabolic syndrome.
Weight loss is an additional potential mechanism by
which low-GI diets may contribute to reduced risk of met-
abolic syndrome.
Induction of a rapid initial weight loss with low-carbohy-
drates diets may be partly explained by a reduction in
overall caloric intake, which may be the result of a great
limitation of food choices by the requirements of mini-
mizing carbohydrates intake [28,29], to the initial
increase in circulating β-hydroxybutyrate, which may sup-
press appetite [30] and to the satiating effect of low-carbo-
hydrates diets containing relatively high amounts of
protein [31,32]. Some of the initial weight loss may also
be explained by a reduction of glycogen stores from liver
(5% of liver weight) and muscle (1% of muscle weight).
Each gram of glycogen is stored with approximately 3 g of
water [33]. Therefore a weight loss of 1–2 kg can theoreti-
cally be achieved within the first week of the diet because
of substantial glycogen reductions in liver and muscle and
excretion of the liberated water in urine [15]. Depending
on the rate of glycogen depletion, this process may last up
to 7–14 days, after which weight loss slows [34]. It should
be noticed in this respect that loss of glycogen and water
is not a true measure of weight loss, as their stores will be
replenished once the diet is stopped [15].
The rapid large rise in blood glucose following consump-
tion of high-GI food triggers a large insulin response and
strongly inhibits glucagons release. For most foods, a
good correlation exists between glucose and insulin
responses, with high-GI foods eliciting large insulin
responses [35], which trigger rapid uptake of nutrients by
insulin-responsive tissues and suppress nutrient mobiliza-
tion. Glucose uptake and glycogen synthesis in skeletal
muscle and liver, and lipogenesis in adipose tissue, are
increased. Simultaneously, gluconeogenesis and glucose
out put by liver and lipolysis are suppressed.
Low-GI diets give a more stable diurnal profile, reducing
postprandial hyperglycaemia and hyperinsulinaemia, and
attenuating late postprandial rebounds in circulating free
fatty acids, all factors that exacerbate various components
of the metabolic syndrome [23].
B. Insulin resistance and insulin secretion
High circulating free fatty acids levels result in lipid accu-
mulation in skeletal muscle and liver, causing insulin
resistance in these normally insulin-responsive tissues
[36,37], which reduces insulin-stimulated glycogen syn-
thesis in skeletal muscle (the primary pathway for non-
oxidative glucose disposal in normal subjects [38] and
decrease the ability of insulin to suppress hepatic glucose
production and output.
Insulin sensitivity may be negatively affected in the long
term as low- carbohydrates, high-fat diets favor an
increase of plasma circulating free fatty acids [39,40],
which under usual dieting conditions is typically associ-
ated with many insulin-resistant states in humans [41,42].
Altered fatty acid metabolism contributes to insulin resist-
ance because of alterations in the partitioning of fatPage 3 of 8
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lation of fatty acid and fatty acid metabolites in these insu-
lin-responsive tissues leads to acquired insulin signaling
defects and insulin resistance resulting in a reduced glu-
cose transport [43]. The later is thought to results from
fatty-acid-induced alterations in upstream insulin signal-
ing events, resulting in decreased GLUT 4 translocation to
the plasma membrane. Increased level of intracellular
fatty acid metabolites, such as diacylglycerol, fatty acyl
CoA's, or ceramides activates a serine/threonine kinase
cascade, possibly initiated by protein kinase C. The latter
leads to a non-desired phosphorylation of serine/threo-
nine sites on insulin receptor substrates, which then fail to
associate with or to activate PI 3-kinase, resulting in
decreased activation of glucose transport and other down-
stream events [15].
Fig. 2Regulation of insulin secretion by glucose and lip-
ids (adapted by Brand et al. (2004). Free Radic. Biol.
Med.).
It is observed an inverse relationship between adiponectin
and insulinsensivity. Adiponectin is similar in structure to
TNF-α (tumor necrosis factor α) which paradoxically
appears to be increased in abdominal adipose tissue.
Increases in proinflammatory cytokines (interleukine 6,
TNF-α, resistin, C- reactiv protein – CRP) reflect overpro-
duction by the expanded adipose tissue mass [44,45]. All
of these factors contribute to the exaggerated release of
free fatty acids from abdominal adipocytes into the portal
system. Free fatty acids have deleterious effects on insulin
uptake by the liver and contribute to the increased hepatic
gluconeogenesis and hepatic glucose release observed in
central obesity [46].
High glucose levels have a glucotoxic effect on β-cells,
probably as a result of free radical oxidative damage [47].
Hyperinsulinaemia may reduce β-cell function by causing
excess amyloid deposits [48]. High free fatty acids levels
lead to triacylglycerol accumulation in β-cells, which
reduces insulin secretion [49]. Accordingly, by reducing
hyperglycaemia, hyperinsulinemia and free fatty acids lev-
Low GI diets and metabolic syndromeFigure 1
Low GI diets and metabolic syndrome. Description: Low GI diets decrease insulin resistance and insulin levels, causing 
plasma glucose reduction, decrease free fatty acids levels, inflammation and endothelial dysfunction, causing an important 
reduction of cardiovascular risk factors.Page 4 of 8
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β-cell failure [23].
C. Dyslipidaemia
Hyperinsulinaemia and insulin resistance are significantly
correlated to dyslipidaemia and contribute to the charac-
teristic alteration of plasma lipid profile associated with
obesity.
Low-GI diets may reduce insulin-stimulated activity of 5-
hydroxi-3-methylglutaryl-CoA reductase, the rate-limiting
enzyme involved in cholesterol synthesis, by reducing
insulin levels. Dietary fiber tends to reduce bile acid and
cholesterol re-absorption from the ileum, which may
inhibit hepatic cholesterol synthesis [47].
Low-carbohydrates diets as well as low-fat diets signifi-
cantly decreased several biomarkers of inflammation
(CRP, TNF-α, IL-6), which play a key role in all stages of
the pathogenesis of atherosclerosis [15].
D. Cardiovascular risk factors
Hyperglicaemia is a continuous risk factor for CVD mor-
bidity and mortality.
The effects of cytokines on peripheral tissues with
increased intracellular lipids also lower cellular insulin
sensitivity: the surge in lipids promotes proliferation of
the vasa vasorum of the arterial media and apoptosis by
the medial macrophages with a further release of
cytokines. There is an additional complex relationship
through an associated pro-inflammatory state and altera-
tions in coagulation. A rise in blood viscosity is induced
Regulation of insulin secretion by glucose and lipidsFig re 2
Regulation of insulin secretion by glucose and lipids. Description: Insulin secretion is influenced by plasma glucose and 
lipids that activate on one hand glycolysis and production of pyruvate, and on the other hand β-oxidation and ATP synthesis.Page 5 of 8
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inhibitor 1 from adipocytes with a fall in plasminogen
activator. These changes may explain the role of obesity as
a promoter of intracellular inflammatory processes that
result in arterial damage. Ethnic differences in CRP may
explain some of the variation observed in insulin resist-
ance across populations with comparable weight gain and
associated medical complications [46].
A low-GI diet may have beneficial effects on thrombolytic
function. The activity of plasminogen activator inhibitor-
1, a thrombolytic factor that increases clot and plaque for-
mation, has been found to be 53% lower after 24 days on
a low -GI diet compared with a high-GI diet in twenty sub-
jects with type 2 diabetes [50].
Long-term studies are clearly required, as recently, an
increased plasma homocysteine level (+6.6%) was
observed in individuals that follow strictly a low- carbohy-
drates diet for several months [51]. In contrast, a low-fat
diet induced a decrease of plasma homocysteine by 6–8%.
This may be an important observation as the relationship
between total plasma homocysteine and CVD is dose
dependent and independent of other risk factors. In
humans, the effects of homocysteine on endothelial and
vascular function and blood coagulation provide explana-
tions for increased CVD risk [15,52,53].
The effects of increased body fatness on cardiovascular
function can be predicted. Total body oxygen consump-
tion is increased because of an expanded lean tissue mass
and metabolically active adipose tissue, and this is accom-
panied by an absolute increase in cardiac output. The total
blood volume in obesity is increased in proportion to
body weight. This increase in blood volume contributes to
an increase to the left ventricular pre-load and an increase
in resting cardiac output. The increased demand for car-
diac output is achieved by an increase in stroke volume:
an increase in stroke volume results from an increase in
diastolic filling of the left ventricle. This thickening of the
wall with dilatation results in eccentric hypertrophy. The
cardiovascular adaptation to the increased intravascular
volume of obesity may not completely restore normal
homodynamic function. Marked systolic dysfunction
occurs when the ventricle can no longer adapt to volume
overload. Dilatation of the left ventricle cavity radius leads
to a decline in ventricular contractility. A combination of
systolic and diastolic dysfunction progresses to heart fail-
ure [46,54]. Hyperglicaemia exacerbates oxidative stress,
which is associated with inflammation, increased blood
pressure, accelerated clot formation and decreased
endothelium-dependent blood flow [47,55], and which
may also worsen insulin resistance [56].
Conclusion
Long term compliance to a low-GI diet may induce favo-
rable metabolic effects.
A diet high in fruits and vegetables, whole grains and low
fat dairy products are important for weight loss.
Reduced hyperinsulinaemia associated with a low-GI diet
may reduce CVD risk through effects on oxidative stress,
blood pressure, serum lipids, coagulation factors, inflam-
matory mediators, endothelial function and thrombolytic
function [47,49,55-57].
Based on associations between these metabolic parame-
ters and risk of disease, further controlled studies on low-
GI diet and metabolic disease are needed [58,59].
Data from long term clinical trials on the metabolic effects
on different diets are needed in this area.
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